Tuesday, January 18, 2022
Home Tags Subject expert commity

Tag: Subject expert commity

CDSCO panel weighing risks and benefits of Covid drug Molnupiravir

Antiviral Covid-19 pills People in the know said that Molnupiravir, which received emergency use authorisation (EUA) from the USFDA on Thursday, is likely...

Latest posts

Pharmaceutical Budget 2022: Expectations

India needs to build a vibrant ecosystem to emerge as an innovation hub in generics: Poornachandra Tejasvi, Senior Director, Emerging Markets...

Authors

61 POSTS0 COMMENTS
30 POSTS0 COMMENTS
24 POSTS0 COMMENTS
15 POSTS0 COMMENTS
11 POSTS0 COMMENTS
11 POSTS0 COMMENTS
5 POSTS0 COMMENTS
5 POSTS0 COMMENTS
5 POSTS0 COMMENTS
4 POSTS0 COMMENTS
4 POSTS0 COMMENTS
3 POSTS0 COMMENTS
2 POSTS0 COMMENTS
2 POSTS0 COMMENTS
1 POSTS0 COMMENTS
1 POSTS0 COMMENTS
1 POSTS0 COMMENTS